Ceragenix Pharmaceuticals

Ceragenix loses almost $13M in 2005
Denver Business Journal - The Denver company (OTCBB: CGXP), which doesn't have any revenue yet, has lost $13.8 million since 2002. During 2004, the company posted a net loss of $825,711. The red ink amounted to a loss of $1.06 per share last year, up from a loss of 7 cents